Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancer

Chethan Ramamurthy, Elizabeth A. Handorf, Andres F. Correa, J. Robert Beck, Daniel M. Geynisman

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences